Search for: "Ranbaxy Laboratories Ltd." Results 1 - 20 of 70
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 May 2021, 7:34 am by Deb Givens
  A federal judge has approved multiple classes in litigation accusing Indian generic drugmaker Ranbaxy Laboratories Ltd of delaying the launch of generic drugs by submitting false applications to U.S. regulators. [read post]
16 Apr 2018, 2:48 pm by Lawrence B. Ebert
Ranbaxy Laboratories Ltd., Ranbaxy soughtto limit a claim depicting a specific three-dimensionalorientation to a racemic mixture. 457 F.3d 1284, 1288–89(Fed. [read post]
18 Jul 2014, 11:55 am
Lake Asbestos of Quebec, Ltd., 1986 WL 69060, at *5-6 (N.D. [read post]
3 Jul 2014, 7:42 am by Robert Kraft
The article pointed out that Sun this month unveiled a plan to buy Ranbaxy Laboratories Ltd., which itself has come under FDA scrutiny, with four of its plants banned by the FDA. [read post]
14 Mar 2014, 8:01 am
Indian drug maker Ranbaxy Laboratories Ltd. is facing harsh criticism after issuing a recall for more than 60,000 bottles of its generic cholesterol-lowering drug Lipitor. [read post]
18 Feb 2014, 12:43 pm by Dennis Crouch
Ranbaxy Laboratories Ltd., 457 F.3d 1284 (Fed. [read post]
24 Jan 2014, 7:36 am by m zamora
Ranbaxy Laboratories Ltd. can’t make or distribute drug ingredients from a fourth plant in India for the U.S. market, regulators ordered. [read post]
23 Oct 2013, 9:30 pm by Pooja Agarwal
    Last month, the Food and Drug Administration (FDA) issued an import alert, prohibiting the manufacture of FDA-regulated drugs at the Mohali, India plant of Ranbaxy Laboratories, Ltd., an international pharmaceutical company. [read post]
10 Oct 2013, 8:42 am by Jonathan Tycko
Ranbaxy USA Inc. ($500 Million) Ranbaxy USA Inc., a subsidiary of Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited, agreed to pay a total of $500 million to settle criminal and civil allegations filed against the company. [read post]
18 Sep 2013, 1:51 am by Kevin LaCroix
Food and Drug Administration, as part of its effort to block exports to the United States from the Indian drug manufacturing plant of Indian-based Ranbaxy Laboratories Ltd due to alleged safety violations, the U.S. agency has required the company “to hire a third-party expert to inspect the Mohali facility and certify to the FDA that any violations have been addressed and that the company has processes in place to ensure continuing compliance. [read post]
30 Jun 2013, 1:12 pm by Sai Vinod
The petition is more or less similar to Super Cassettes Industries Ltd. [read post]
3 Mar 2013, 12:06 pm by Rajiv Kr. Choudhry
Patil 337/DELNP/2003 LANXESS DEUTSCHLAND GMBH Granted Dr.Rajesh Dixit 4069/DELNP/2006 RANBAXY LABORATORIES LIMITED Withdrawn Hardev Karar 106/DELNP/2008 ALFA WASSERMANN S. [read post]
12 Jul 2012, 7:37 am by Tom Kosakowski
In the past six months, HUL (Hindustan Unilever Ltd.), Ranbaxy Laboratories, SKS Microfinance Ltd., and Wipro Ltd. have created Ombuds offices. [read post]